Clinical Trial Update: Rapid Delivery of Autologous Bone Marrow Derived Stem Cells in Acute Myocardial Infarction Patients. [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes rapid delivery of autologous bone marrow-derived stem cells in patients with acute myocardial infarction, across Phase 1 an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Autologous bone marrow-derived stem cell therapy

Snippet

Sponsor: TotipotentRX Cell Therapy Pvt. Ltd. | Conditions: Acute Myocardial Infarction | Phase 1, Phase 2 | Status: UNKNOWN